DNA X, Inc. Common Stock
SONM
SONM
12 hedge funds and large institutions have $346K invested in DNA X, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $435K → $346K (-$88.7K)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$63.7K | |
| 2 | +$46.6K | |
| 3 | +$27.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.9K |
| 5 |
SG
StoneX Group
New York
|
+$7.23K |
Top Sellers
| 1 | -$21K | |
| 2 | -$21K | |
| 3 | -$17K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.63K |
| 5 |
Citigroup
New York
|
-$2.71K |